Critical appraisals and clinical takeaways that separate signal from noise.

The TASC Trial: Therapeutic vs Prophylactic Anticoagulation for Acute Chest Syndrome

In adults with sickle cell disease hospitalized for acute chest syndrome (ACS) without pulmonary artery macrothrombosis, does therapeutic-dose anticoagulation with tinzaparin shorten ACS duration compared with prophylactic-dose anticoagulation?

Hematology and Oncology
Showing Slide 1 of 2

Evidence-based • Practical • Trusted by millions of clinicians each year

Get new posts (free)

1 email per week. No spam.

Sponsored

Get new posts (free)

1 email per week. No spam.

Sponsored